Histamine Blood Concentration in Ischemic Heart Disease Patients
Figure 1
Histamine blood concentration (ng mL−1) in control group (), as well as in the patients with coronary diseases: stable coronary artery disease (SCAD, ), acute coronary syndrome, nonocclusive type (ACS-UA, ), and acute coronary syndrome, occlusive type (ACS-STEMI, ), during the testing period of eight days. The data are presented by means ± SEM.